Free Consultation


Alan J Garber

Alan J Garber


Endocrinologist

Ridha Arem, M.D.

Alan-J-Garber

Alkek Building for Biomedical Research
ABBR R-618
Mail Stop: BCM 185
Houston, Texas 77030
United States
(713) 798-0153
[email protected]


POSITIONS Professor Medicine, Biochemistry, and Molecular & Cellular Biology Endocrinology, Diabetes and Metabolism Baylor College of Medicine Houston, TX, US

Education

PhD from Fels Research Institute
01/1971 – Philadelphia, PA, United States
Physiological Chemistry
Internship at Temple University
01/1969 – Philadelphia, PA, United States
Internal Medicine
Fellowship at Barnes Hospital
01/1972 – St. Louis, MO, United States
Metabolism
Residency at Temple University Hospital
01/1972 – Philadelphia, United States
Internal Medicine

Certifications

#AG6347896
DEA
#S0025835
DPS
#1386724631
NPI

Honors & Awards

Best Doctors in America
Best Doctors in America
1994 – 2018
Distinguished Alumni Achievement Award
Temple University School of Medicine

ADA Outstanding Leadership Award
American Diabetes Association

AACE President
American Association of Clinical Endocrinologists

Special Government Employee-FDA
National Institutes of Health

Albert Nelson Marquis Lifetime Achievement Award
Marquis Who’s Who

NLA Honorary Lifetime Member Award
National Lipid Association

ADA Distinguished Service Award
American Diabetes Association

Master of the American College of Endocrinology
American Association of Clinical Endocrinologists

Professional Interests

Diabetes, Cardiovascular Disease, Hyperlipidemia

Memberships

American Association of Clinical Endocrinologists

American Diabetes Association

American College of Endocrinology

American Medical Association

National Lipid Association

The Endocrine Society

Selected Publications

“American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia..” Pubmed PMID: 29655268

Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, . “American association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary..” Endocr Pract. 17(2):287-302. Pubmed PMID: 21474421

“AACE/ACE 2018 Position Statement on Insulin Pumps and Continous Glucose Monitoring.” Pubmed PMID: 29547046

“AACE/ACE Type 2 Diabetes Management Algorithm, Consensus Statement and Executive Summary.” Pubmed PMID: 29368965

“AACE Position Statement on the use of  Follow-on Biologist and Biosimilars for Endocrine Diseases.” Pubmed PMID: 29190135

“AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of CVD Executive Summary.” Pubmed PMID: 28437620

“AACE/ACE Guidelines for Dyslipidemia and Prevention of CVD.” Pubmed PMID: 28156151

“AACE/ACE Consensus Statement on the Comprehensive Type 2 Diabetes Management  Algorithm 2017 Executive Summary.” Pubmed PMID: 28095040

“A Plethora of GLP-1 Agonists: Decisions About What to Use and When.” Pubmed PMID: 27766579

“AACE/ACE Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis.” Pubmed PMID: 27082665

“AACE/ACE Clinical Practice Guidelines for Comprehensive Medical Care of Patients With Obesity.” Pubmed PMID: 27472012

“AACE/ACE 2016 Comprehensive Type 2 Diabetes Algorithm, Consensus Statement and Executive Summary.” Pubmed PMID: 26731084

“Addressing Cardiovascular Risk in Type 2 Diabetes.”

“Dysglycemia-Based Chronic Disease: An AACE Position Statement.”

“Aspirin in Primary Prevention for Patients With Type 2 Diabetes.”